UBS AM
SHC icon

UBS AM’s Sotera Health SHC Stock Holding History

UBS AM’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.36M Buy
470,803
+33,221
+8% +$524K ﹤0.01% 1343
2026
Q1 		$6.27M Sell
437,582
-5,078
-1% -$84.3K ﹤0.01% 1455
2025
Q4 		$7.81M Buy
442,660
+124,221
+39% +$2.05M ﹤0.01% 1238
2025
Q3 		$5.01M Sell
318,439
-213,908
-40% -$3M ﹤0.01% 1368
2025
Q2 		$5.92M Buy
532,347
+189,413
+55% +$2.22M ﹤0.01% 1633
2025
Q1 		$4M Buy
342,934
+43,471
+15% +$559K ﹤0.01% 1680
2024
Q4 		$4.1M Buy
299,463
+37,468
+14% +$543K ﹤0.01% 1710
2024
Q3 		$4.38M Sell
261,995
-14,842
-5% -$217K ﹤0.01% 1647
2024
Q2 		$3.29M Buy
276,837
+115,465
+72% +$1.32M ﹤0.01% 1727
2024
Q1 		$1.94M Hold
161,372
– – ﹤0.01% 1705
2023
Q4 		$2.72M Buy
161,372
+4,004
+3% +$56.7K ﹤0.01% 1533
2023
Q3 		$2.36M Buy
157,368
+8,853
+6% +$149K ﹤0.01% 1538
2023
Q2 		$2.66M Hold
148,515
– – ﹤0.01% 1522
2023
Q1 		$2.66M Buy
148,515
+11,507
+8% +$192K ﹤0.01% 1522
2022
Q4 		$1.14M Buy
137,008
+17,923
+15% +$134K ﹤0.01% 1796
2022
Q3 		$812K Sell
119,085
-13,228
-10% -$220K ﹤0.01% 2093
2022
Q2 		$2.59M Buy
132,313
+4,529
+4% +$94.9K ﹤0.01% 1510
2022
Q1 		$2.77M Buy
127,784
+15,318
+14% +$325K ﹤0.01% 1623
2021
Q4 		$2.65M Buy
112,466
+16,173
+17% +$387K ﹤0.01% 1737
2021
Q3 		$2.52M Buy
96,293
+16,157
+20% +$391K ﹤0.01% 1723
2021
Q2 		$1.94M Buy
80,136
+48,333
+152% +$1.19M ﹤0.01% 1862
2021
Q1 		$794K Buy
+31,803
New +$841K ﹤0.01% 2191

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

UBS AM's SHC Position: Q2 2026 in Review

UBS AM increased its Sotera Health (SHC) stake by 7.6% in Q2 2026, buying an estimated $524K and bringing the position to 470,803 shares worth $8.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1343.

UBS AM first reported a position in SHC in Q1 2021 and has held it in 22 quarters since. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • UBS AM held 470,803 shares of Sotera Health worth $8.36M as of Q2 2026.
  • UBS AM bought 33,221 Sotera Health shares in Q2 2026, an estimated $524K.
  • Sotera Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1343 holding.
  • UBS AM first reported a position in Sotera Health in Q1 2021 and has held it in 22 quarters since.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.